Explore different protein purification methods like ion exchange, affinity chromatography, and size exclusion, and understand ...
Findings suggest protein restriction doesn't have to be extreme ...
The top generic drug regulator at the US Food and Drug Administration (FDA) on Wednesday touted the drop in refuse-to-receive ...
Learn about the current medication options for managing type 2 diabetes and chronic kidney disease, including SGLT2 ...
For adults undergoing maintenance in-center hemodialysis, longer dialysis times are associated with better survival, ...
Creating more environmentally sustainable dialysis practices requires collaborative efforts and innovations to the field, ...
A doctor shares the story of a young patient with chronic illnesses who chose to stop dialysis and enter hospice.
A new UC Davis Health study reveals that transportation challenges create major barriers for patients with end-stage kidney disease who receive hemodialysis at a clinic. These challenges also have a ...
In the latest tranche of published warning letters, the US Food and Drug Administration (FDA) has continued to go after drugmakers for marketing glucagon-like peptide-1 (GLP-1) receptor agonists and ...
Bottle of Foundayo, a GLP-1 pill from Eli Lilly approved by the FDA to treat obesity Bottle of Foundayo, a GLP-1 pill from Eli Lilly approved by the FDA to treat obesityEli Lilly & Company Senior ...
Gilead Sciences, Inc. today announced the U.S. Food and Drug Administration (FDA) accepted its New Drug Application (NDA) ...